EUR 13.06
(1.08%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 12.53 Million EUR | -17.57% |
2022 | 13.12 Million EUR | -10.83% |
2021 | 23.11 Million EUR | -53.4% |
2020 | 51.62 Million EUR | 254.06% |
2019 | 28.1 Million EUR | 75.03% |
2018 | 9.57 Million EUR | 160.53% |
2017 | -15.65 Million EUR | -141.0% |
2016 | 34.05 Million EUR | 20.78% |
2015 | 71.41 Million EUR | 15.68% |
2014 | 24.37 Million EUR | 255.92% |
2013 | 6.84 Million EUR | 146.03% |
2012 | -6.34 Million EUR | -118.13% |
2011 | 49.37 Million EUR | 98.68% |
2010 | 25.99 Million EUR | 46.96% |
2009 | 25.71 Million EUR | -32.59% |
2008 | 41.68 Million EUR | 125.03% |
2007 | 15.91 Million EUR | -54.89% |
2006 | 37.06 Million EUR | 150.66% |
2005 | 17.68 Million EUR | -70.88% |
2004 | 56.25 Million EUR | 18.8% |
2003 | 47.35 Million EUR | -17.99% |
2002 | 57.74 Million EUR | -16.21% |
2001 | 68.91 Million EUR | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | -372 Thousand EUR | 0.0% |
2023 FY | - EUR | -17.57% |
2023 Q4 | 32.81 Million EUR | 0.0% |
2023 Q2 | -14.87 Million EUR | 0.0% |
2022 Q4 | 12.15 Million EUR | 0.0% |
2022 Q2 | 9.6 Million EUR | 0.0% |
2022 FY | - EUR | -10.83% |
2021 Q4 | 18.81 Million EUR | 0.0% |
2021 FY | - EUR | -53.4% |
2021 Q2 | 5.58 Million EUR | 0.0% |
2020 Q2 | -4.46 Million EUR | 0.0% |
2020 Q4 | 56.82 Million EUR | 0.0% |
2020 FY | - EUR | 254.06% |
2019 FY | - EUR | 75.03% |
2019 Q2 | -1.97 Million EUR | 0.0% |
2019 Q4 | 14.49 Million EUR | 0.0% |
2018 Q2 | -3.16 Million EUR | 0.0% |
2018 FY | - EUR | 160.53% |
2017 FY | - EUR | -141.0% |
2017 Q2 | 2.83 Million EUR | 0.0% |
2016 Q4 | 20.75 Million EUR | 0.0% |
2016 FY | - EUR | 20.78% |
2016 Q2 | 13.29 Million EUR | 0.0% |
2015 Q2 | 15.23 Million EUR | 0.0% |
2015 Q4 | 12.96 Million EUR | 0.0% |
2015 FY | - EUR | 15.68% |
2014 Q2 | 11.54 Million EUR | 0.0% |
2014 FY | - EUR | 255.92% |
2013 Q4 | -133 Thousand EUR | 0.0% |
2013 FY | - EUR | 146.03% |
2013 Q2 | 6.98 Million EUR | 0.0% |
2012 FY | - EUR | -118.13% |
2012 Q4 | 490.5 Thousand EUR | -38.34% |
2012 Q3 | 795.5 Thousand EUR | 0.0% |
2012 Q2 | 795.5 Thousand EUR | 0.0% |
2012 Q1 | 795.5 Thousand EUR | 0.0% |
2011 Q2 | 3.91 Million EUR | 0.0% |
2011 Q4 | 795.5 Thousand EUR | -79.69% |
2011 FY | - EUR | 98.68% |
2011 Q3 | 3.91 Million EUR | 0.0% |
2011 Q1 | 3.91 Million EUR | 0.0% |
2010 Q3 | 10.32 Million EUR | 0.0% |
2010 FY | - EUR | 46.96% |
2010 Q4 | 3.91 Million EUR | -62.06% |
2010 Q1 | 10.32 Million EUR | 0.0% |
2010 Q2 | 10.32 Million EUR | 0.0% |
2009 FY | - EUR | -32.59% |
2009 Q3 | 7.02 Million EUR | 0.0% |
2009 Q2 | 7.02 Million EUR | 0.0% |
2009 Q4 | 10.32 Million EUR | 46.96% |
2009 Q1 | 7.02 Million EUR | 0.0% |
2008 FY | - EUR | 125.03% |
2008 Q4 | 7.02 Million EUR | -0.08% |
2008 Q3 | 7.03 Million EUR | 0.0% |
2008 Q2 | 7.03 Million EUR | 0.0% |
2008 Q1 | 7.03 Million EUR | 0.0% |
2007 Q4 | 7.03 Million EUR | -13.45% |
2007 FY | - EUR | -54.89% |
2007 Q1 | 8.12 Million EUR | 0.0% |
2007 Q2 | 8.12 Million EUR | 0.0% |
2007 Q3 | 8.12 Million EUR | 0.0% |
2006 FY | - EUR | 150.66% |
2006 Q4 | 8.12 Million EUR | -8.62% |
2006 Q2 | 8.88 Million EUR | 0.0% |
2006 Q1 | 8.88 Million EUR | 0.0% |
2006 Q3 | 8.88 Million EUR | 0.0% |
2005 Q2 | 4.5 Million EUR | 0.0% |
2005 Q3 | 4.5 Million EUR | 0.0% |
2005 FY | - EUR | -70.88% |
2005 Q4 | 8.88 Million EUR | 97.45% |
2005 Q1 | 4.5 Million EUR | 0.0% |
2004 Q2 | 14.06 Million EUR | 0.0% |
2004 Q4 | 4.5 Million EUR | -67.99% |
2004 FY | - EUR | 18.8% |
2004 Q1 | 14.06 Million EUR | 0.0% |
2004 Q3 | 14.06 Million EUR | 0.0% |
2003 Q1 | 11.83 Million EUR | 0.0% |
2003 Q4 | 14.06 Million EUR | 18.8% |
2003 Q2 | 11.83 Million EUR | 0.0% |
2003 Q3 | 11.83 Million EUR | 0.0% |
2003 FY | - EUR | -17.99% |
2002 Q4 | 11.83 Million EUR | -17.99% |
2002 Q3 | 14.43 Million EUR | 0.0% |
2002 Q1 | 14.43 Million EUR | 0.0% |
2002 Q2 | 14.43 Million EUR | 0.0% |
2002 FY | - EUR | -16.21% |
2001 FY | - EUR | 0.0% |
2001 Q4 | 14.43 Million EUR | -16.21% |
2001 Q3 | 17.22 Million EUR | 0.0% |
2001 Q1 | 17.22 Million EUR | 0.0% |
2001 Q2 | 17.22 Million EUR | 0.0% |
2000 Q4 | 17.22 Million EUR | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Affluent Medical SA | -13.34 Million EUR | 193.907% |
Bluelinea Société Anonyme | -323.98 EUR | 3867622.687% |
Carmat SA | -50.45 Million EUR | 124.835% |
Diagnostic Medical Systems S.A. | -7.05 Million EUR | 277.554% |
Euromedis Groupe | -4.43 Million EUR | 382.513% |
Eurobio Scientific Société anonyme | 18.98 Million EUR | 34.004% |
Ikonisys S.A. | -2.34 Million EUR | 633.753% |
Implanet S.A. | -5.07 Million EUR | 346.799% |
Median Technologies SA | -19.58 Million EUR | 163.978% |
SpineGuard SA | -3.49 Million EUR | 458.326% |
Theraclion SA | -4.48 Million EUR | 379.236% |
Euroapi S.A. | -155.39 Million EUR | 108.063% |
Guerbet SA | 98.83 Million EUR | 87.323% |
Koninklijke Philips N.V. | 1.04 Billion EUR | 98.796% |
Sequana Medical NV | -29.13 Million EUR | 143.004% |